Anbio Biotechnology Increase (Decrease) in Accounts Receivable
Anbio Biotechnology (NNNN) reported Increase (Decrease) in Accounts Receivable of $2.59 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-04-07.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-04-07
| Period end | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|
| 2025-12-31 | $2.59M 20-F · filed 2026-04-07 |
| 2024-12-31 | -$820.17K 20-F · filed 2026-04-07 |
| 2023-12-31 | $1.88M 20-F · filed 2026-04-07 |
| 2022-12-31 | -$717.50K 20-F · filed 2025-04-28 |